Enbrel ruling lifts Amgen shares

Enbrel ruling lifts Amgen shares

Source: 
BioCentury
snippet: 

A decision by the U.S. District Court for the District of New Jersey late Friday removed a key overhang on Amgen shares when it upheld two Enbrel patents at stake in a suit against Sandoz.